Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S.
GENIL.IS
Istanbul Stock Exchange11.20
TRY
+0.39
- -
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S.
GENIL.IS
(Istanbul Stock Exchange)
Recent
price
11.20
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret A.S. (GENIL.IS) is a Turkish manufacturer and distributor of dietary supplements, health and wellness products, and consumer health goods, operating from its headquarters in Istanbul, Turkey, and serving regional and international markets. The company develops, manufactures, and markets a range of products through its branded lines and private-label programs, including vitamin and mineral supplements, probiotic formulations, specialty nutrition products, herbal and plant-based remedies, and over-the-counter health products; it provides contract manufacturing and formulation development services, product registration support, quality assurance and regulatory compliance, packaging design, and logistics services to third-party brands. Core product categories include dietary supplements (oral tablets, capsules, softgels, powders, gummies), nutritional beverages and powders, probiotic products, functional foods, nutraceuticals, and cosmetic and personal care items. The firm maintains a vertically integrated supply chain with in-house manufacturing capabilities, quality control laboratories, and finished-product distribution, enabling scale across domestic and international markets. GENIL focuses on partnerships with pharmaceutical and healthcare distributors, retailers, e-commerce platforms, and private-label customers across Europe, the Middle East, Africa, and other regions, delivering full-service support from development to regulatory approval, manufacturing, packaging, and post-market surveillance. Recent major changes include strategic partnerships and alliances to expand product formulations and geographic reach; expansion of contract manufacturing for international brands; launches of new product lines in immunology-support and senior-nutrition segments; notable acquisitions or reorganizations within the last 1–2 years to enhance manufacturing capacity, quality systems, and global distribution; and ongoing corporate reorganizations to optimize supply chain resilience and regulatory compliance. The company also reports ongoing investments in downstream processing, quality assurance enhancements, and modernization of facilities to meet evolving international standards. GENIL operates in the nutraceuticals and consumer health sectors, servicing health-focused retailers, wholesalers, pharmacies, hospitals, and direct-to-consumer channels, with a focus on high-quality, scientifically-formulated products, robust regulatory compliance, and reliable supply chain execution. Subsidiaries and parent relationships support regional manufacturing and distribution capabilities within Turkey and abroad, reinforcing GENIL’s position in the global health products market.